Pure Global

Product - Vietnam Registration 230003118/PCBB-HN

Access comprehensive regulatory information for Product in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại B medical device is registered under number 230003118/PCBB-HN and manufactured by CPC1 Pharmaceutical Corporation, Hanoi.

This page provides complete technical specifications, regulatory compliance details, 5 companies making similar products including MetaSystems Probes GmbH, Fujifilm Irvine Scientific, Inc, and 5 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
5 Competitors
5 Recent Registrations
230003118/PCBB-HN
Registration Details
Vietnam MOH Registration: 230003118/PCBB-HN
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Product
VN: Sản phẩm
Neobaby
Risk Class TTBYT Loại B

Registration Details

230003118/PCBB-HN

000.00.19.H26-231120-0013

TCCS-15B:2023/CPC1HN

Company Information

Technical Details

-Simethicone helps alleviate symptoms such as vomiting, colic, digestive disorders, bloating, indigestion, abdominal pain, intestinal cramps, and other gastrointestinal symptoms in infants, children, and adults. -Simethicone works by breaking up gas bubbles in the digestive tract, thus quickly reducing uncomfortable symptoms (pain, cramping, bloating, gas, ...) associated with bloating. -Saccharomyces boulardii, a probiotic, helps restore the balance of the gut flora, preventing and treating digestive disorders, diarrhea, acute diarrhea, and other gastrointestinal issues. -Simethicone and Saccharomyces boulardii together provide both immediate relief and support for a healthy digestive system, enhancing digestion and nutrient absorption to promote overall health.

Dates and Status

Nov 27, 2023